CRONSMALL

Cronos Group Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$2.62
$0.00(-0.38%)
52W$1.84
$3.43
Updated May 7, 12:00 AM
RSI50
RS Rating50/99
Beta0.98
Volatility46%
F-Score6/9
Mkt Cap$1000M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Cronos Group Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 50), indicating performance broadly in line with the market. Earnings contraction of 100% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
50
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.98
vs S&P 500
MARKET
52W Position
49%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.59
50 SMA > 100 SMA$2.65
100 SMA > 150 SMA$2.60
150 SMA > 200 SMA$2.56

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.65-1.26%BELOW
50 SMA$2.59+1.05%ABOVE
100 SMA$2.65-1.05%BELOW
150 SMA$2.60+0.72%ABOVE
200 SMA$2.56+2.30%ABOVE

Price Performance

1D-0.4%
1W+1.6%
1M+1.6%
3M-0.8%
6M+6.1%
YTD-3.0%
1Y+41.6%
3Y+9.6%
52-Week Trading Range49% from low
$2.62
52W Low$1.84
52W High$3.43

Technical Indicators

RSI (14)NEUTRAL
50.0
305070
VCP ScoreCOOL
4/10
Base depth: 33.4%

Risk Profile

Beta
0.98
52W Vol
46%
ATR
$0.15
Max DD (1Y)
-27%

Volume Analysis

Today
973.1K
50D Avg
1.44M
Vol Ratio
0.68x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25+372%
$0.02
Q2'25-337%
$-0.10
Q3'25+210%
$0.07
Q4'25-100%
$0.00
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+49.77%
5 Years:+32.85%
3 Years:+30.63%
TTM:+64.40%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-116.72%

Stock Price CAGR

10 Years:+31.85%
5 Years:-19.23%
3 Years:+9.60%
1 Year:+41.62%

Return on Equity

10Y Avg:4.7%
5Y Avg:-8.7%
3Y Avg:-1.2%
Last Year:-0.9%

Key Metrics

Market Cap$1000M
Gross Margin32.5%
Net Margin-4.9%
Piotroski F-Score6/9

Frequently Asked Questions

Is CRON in an uptrend right now?

CRON has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is CRON overbought or oversold?

CRON's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.

Is CRON outperforming the market?

CRON has a Relative Strength (RS) Rating of 50 out of 99. CRON is performing about average compared to the market.

Where is CRON in its 52-week range?

CRON is trading at $2.62, which is 76% of its 52-week high ($3.43) and 49% above its 52-week low ($1.84).

How volatile is CRON?

CRON has a Beta of 0.98 and 52-week volatility of 46%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.